Home/Investors/VIB

VIB

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

10

Top Stage

Phase 2

Investment Focus

Inflammatory Bowel Diseases Pouchitis Inflammatory Diseases Immune-Oncology Infectious Diseases Neuroinflammatory Diseases Autoimmune Diseases Neurodegenerative Diseases Ophthalmic Diseases Oncology

Portfolio Companies

Company	Stage	Valuation	Focus
MRM Health	Phase 2	—	Inflammatory Bowel Diseases, Pouchitis
ExeVir	Phase 1	—	Infectious Diseases
Montis Biosciences	Pre-clinical	—	Neuroinflammatory Diseases, Autoimmune Diseases

Frequent Co-Investors

Droia Ventures1 shared Pfizer Ventures1 shared Biocodex1 shared Sambrinvest1 shared UCB Ventures1 shared ATHOS1 shared SFPIM1 shared Ackermans & van Haaren1 shared